Drawing for ZINCOVER

USPTO serial 79121813

ZINCOVER

Reviewed by CopyMark Law Group

Reg. 4416479Status 709
Filing date
Status date
Registration date
Oct 15, 2013
Examiner
ORNDORFF, LINDA
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ZINCOVER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Wayne V. Harper

2112 W. Marjory AvenueTampa, FL 33606UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
003Soaps for body, soaps for household purposes, soaps for personal use, shampoos for personal use, all or in part containing zincSECTION 71 - CANCELLED—
005Pharmaceuticals for human health for the treatment of anemia and assisting energy metabolism; systemic anti-infectives, namely, antibacterial and antifungal pharmaceuticals; musculo-skeletal system pharmaceutical products for the treatment of musculo-skeletal system diseases; cardiovascular pharmaceuticals, namely, diuretics, lipid lowering agents, beta blocking agents, calcium antagonists and other cardiovascular products; pharmaceuticals for the prevention and treatment of disorders of the nervous system, namely, analgesics, psychoanaleptics, psycoleptics, anti-epileptics, central nervous system drugs, anaesthetics, anti-Parkinson preparations; pharmaceuticals for the treatment of respiratory diseases and asthma; dermatological pharmaceutical products; pharmaceuticals for the treatment of hormonal disorders and the prevention of osteoporosis; anti-diabetic pharmaceuticals; pharmaceuticals for the treatment of bone diseases and joint diseases; pharmaceuticals for the treatment of viral and infectious diseases; pharmaceuticals for use as antineoplastic agents; pharmaceuticals for the treatment of immune system related diseases and disorders; pharmaceuticals for the treatment of kidney diseases; pharmaceuticals for ophthalmological use; chemical preparations for medical purposes, namely, vitamin and mineral supplements to support the growth of children, vitamins and dietary supplements to support arousing the appetite, all or in part containing zincSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 15, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 4, 2025INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Mar 3, 2025XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Mar 3, 2025XXCRGENERIC MADRID TRANSACTION CREATED—
Dec 27, 2024INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Apr 26, 2024C71TCANCELLED SECTION 71—
Oct 15, 2022REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
May 13, 2022RNWLINTERNATIONAL REGISTRATION RENEWED—
Jan 22, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 10, 2020NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Jun 10, 202071AGREGISTERED-SEC.71 ACCEPTED—
Jun 10, 2020APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 15, 2020ES71TEAS SECTION 71 RECEIVED—
Apr 14, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 14, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 14, 2020EWORTEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED—
Apr 14, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 14, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 14, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 15, 2018REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Mar 15, 2018NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 3, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 8, 2016NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 16, 2015NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 2, 2014FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 16, 2014FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 16, 2014FIMPFINAL DISPOSITION PROCESSED—
Jan 15, 2014FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 15, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 5, 2013ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jul 30, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 30, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 10, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 27, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 26, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 25, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 25, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 25, 2013ALIEASSIGNED TO LIE—
Jun 20, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 14, 2013RFNTREFUSAL PROCESSED BY IB—
Dec 22, 2012MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 21, 2012RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 20, 2012RFRRREFUSAL PROCESSED BY MPU—
Dec 20, 2012RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 19, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 18, 2012DOCKASSIGNED TO EXAMINER—
Dec 18, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 13, 2012REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance